Filters

See more specimen types...

Other countries

Results: 1 to 20 of 25 (representing 17 labs)

Tests names and labsConditionsGenes and analytesMethods

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
7861205
  • C Sequence analysis of the entire coding region

Amyotrophic lateral sclerosis type 2

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

ALS2 -Related Disorders Testing via the ALS2 Gene

PreventionGenetics
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

AMYOTROPHIC LATERAL SCLEROSIS (ALS) (AUTOSOMAL RECESSIVE)

Laboratorio de Genetica Clinica SL
Spain
44
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis

Asper Biogene Asper Biogene LLC
Estonia
2222
  • C Sequence analysis of the entire coding region

Juvenile Amyotrophic Lateral Sclerosis Type 2 , Sequencing ALS2 Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Invitae Combined Hereditary Dementia and Amyotrophic Lateral Sclerosis Panel

Invitae
United States
4721
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Amyotrophic Lateral Sclerosis Panel

Invitae
United States
1913
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Spastic Paraplegia Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
8658
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Nonprevalent Amyotrophic Lateral Sclerosis Advanced Sequencing Evaluation

Athena Diagnostics Inc
United States
2415
  • C Sequence analysis of the entire coding region

HSP, Complete Recessive Evaluation

Athena Diagnostics Inc
United States
1812
  • C Sequence analysis of the entire coding region

HSP, Supplemental Recessive Evaluation

Athena Diagnostics Inc
United States
159
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis Advanced Evaluation

Athena Diagnostics Inc
United States
1917
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

HSP, Supplemental Sporadic Evaluation

Athena Diagnostics Inc
United States
2422
  • C Sequence analysis of the entire coding region

HSP, Comprehensive Evaluation

Athena Diagnostics Inc
United States
4024
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis

Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health and Science University
United States
1221
  • C Sequence analysis of the entire coding region

AMYOTROPHIC LATERAL SCLEROSIS A.D. & A.R.

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
1111
  • C Sequence analysis of the entire coding region

Single gene testing ALS2

CeGaT GmbH
Germany
31
  • C Sequence analysis of the entire coding region

ALS2

Fulgent Genetics
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

FTD - ALS panel

Genome Diagnostics Laboratory University Medical Center Utrecht
Netherlands
2915
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 25

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center